Arrowstreet Capital, Limited Partnership Legend Biotech Corp Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Legend Biotech Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 4,827 shares of LEGN stock, worth $213,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,827Holding current value
$213,787% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$485 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$265 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$238 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$116 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$106 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.41B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...